Diseases of the Retina Practice Questions

Q: What is a common symptom associated with vitreous hemorrhage?

Sudden loss of vision without pain. ***Sudden loss of vision without pain*** - **Vitreous hemorrhage** often presents as an acute, **painless loss of vision** due to blood obscuring the light path to the retina. - Patients may describe **floaters**, **cobwebs**, or a **reddish tint** to their vision, indicating blood in the vitreous cavity. *Sudden loss of vision with pain* - **Sudden vision loss with pain** is more characteristic of conditions like **acute angle-closure glaucoma** or **optic neuritis**. - Vitreous hemorrhage itself is not typically associated with ocular pain unless there's an underlying painful condition like **neovascular glaucoma**. *Gradual loss of vision with pain* - **Gradual vision loss with pain** is rare and not typical for vitreous hemorrhage. - Painful, gradual vision loss might suggest chronic inflammatory conditions or certain **orbital pathologies**. *Gradual loss of vision without pain* - **Gradual, painless vision loss** is often seen in conditions like **cataracts**, **chronic open-angle glaucoma**, or **diabetic retinopathy without acute hemorrhage**. - Vitreous hemorrhage usually manifests with a more acute onset of symptoms.

Q: Anterior uveitis earliest lesion ?

Aqueous flare. ***Aqueous flare*** - **Aqueous flare** represents the earliest lesion in anterior uveitis due to increased protein content in the anterior chamber, causing light scattering. - This increased protein is a result of **breakdown of the blood-aqueous barrier** and leakage from inflamed ciliary body capillaries. *Keratic precipitates* - **Keratic precipitates (KPs)** are inflammatory cells that adhere to the corneal endothelium, forming later in the disease process. - While characteristic of uveitis, they are not the *earliest* sign of the inflammatory response within the aqueous humor itself. *Circumcorneal congestion* - **Circumcorneal congestion**, also known as ciliary flush, indicates inflammation of the anterior segment of the eye, particularly the ciliary body. - Although an early sign, it is a vascular response and follows the subtle, microscopic changes of protein leakage that constitute aqueous flare. *Blurring of vision* - **Blurring of vision** is a symptom reported by the patient and is a consequence of the inflammatory process (e.g., cell/protein accumulation, corneal edema, iris spasm). - It is not a direct anatomical or physiological lesion but rather a functional impairment resulting from the underlying inflammation.

Q: Which gas is most commonly used with pneumatic retinopexy?

C3F8. ***C3F8*** - **Perfluoropropane (C3F8)** is commonly used in pneumatic retinopexy due to its longer expansion time and greater final volume compared to other gases. - Its prolonged presence in the vitreous cavity allows for sustained tamponade, which is crucial for successful reattachment of the retina in cases of **rhegmatogenous retinal detachment**. *SF6* - **Sulfur hexafluoride (SF6)** is also used in retinal surgery but has a shorter half-life and smaller final volume compared to C3F8. - While effective, its quicker absorption means less sustained tamponade, making it less ideal for pneumatic retinopexy where prolonged tamponade is often desired. *CO2* - **Carbon dioxide (CO2)** is not used for pneumatic retinopexy as it is highly soluble and rapidly absorbed, providing inadequate and non-sustained tamponade. - It is sometimes used during vitrectomy to induce gas-fluid exchange but not as a long-term tamponade agent. *N2* - **Nitrogen (N2)** is not used as a tamponade gas in pneumatic retinopexy. - Medical gases for vitreoretinal surgery are typically fluorinated gases (like SF6 and C3F8) with specific properties for safe and effective intraocular use.

Q: In which type of retinal detachment are retinal tears most commonly observed?

Rhegmatogenous retinal detachment. ***Rhegmatogenous retinal detachment*** - This type of detachment is characterized by a **full-thickness break or tear** in the neurosensory retina, allowing vitreous fluid to pass into the subretinal space. - The term "rhegma" itself is derived from the Greek word for **tear or rupture**, directly indicating the presence of retinal tears. *Secondary retinal detachment* - This is a broad category that encompasses both exudative and tractional retinal detachments, which do not primarily involve retinal tears. - It refers to any retinal detachment that is not rhegmatogenous, meaning the underlying cause is not a retinal break. *Tractional retinal detachment* - This type occurs when **fibrovascular membranes** on the retinal surface contract, pulling the retina away from the underlying retinal pigment epithelium. - While it can lead to retinal tears in some cases, the primary mechanism is **traction**, not a spontaneous tear. *Exudative retinal detachment* - This is caused by the accumulation of **serous fluid** under the retina due to inflammation, vascular leakage, or tumors, without the presence of retinal breaks. - There is no direct involvement of retinal tears; the detachment is due to **fluid accumulation** from compromised retinal or choroidal vessels.

Q: A diabetic patient presents to you with visual acuity of 6/9 in one eye. Further investigations revealed preretinal hemorrhages with neovascularization at the optic disc. What is the next step in management?

Pan-retinal photocoagulation. ***Pan-retinal photocoagulation*** - The presence of **preretinal hemorrhages** and **neovascularization at the optic disc (NVD)** indicates **high-risk proliferative diabetic retinopathy (PDR)**. - **NVD is a high-risk characteristic** for severe vision loss and requires urgent treatment with **pan-retinal photocoagulation (PRP)**. - PRP aims to ablate ischemic peripheral retina, which reduces the production of **VEGF** and other angiogenic factors that stimulate neovascularization. *Focal laser photocoagulation* - This treatment targets discrete leaking microaneurysms in cases of **clinically significant macular edema (CSME)**, which is not the primary issue here. - It is used for **non-proliferative diabetic retinopathy** with macular involvement, not for neovascularization. *Grid laser photocoagulation* - Grid laser is a type of focal laser used for **diffuse macular edema** where specific leaking microaneurysms cannot be identified. - It is not indicated for **neovascularization** or **preretinal hemorrhages**, which are signs of PDR. *Scleral buckling* - **Scleral buckling** is a surgical procedure primarily used to treat **retinal detachment** by indenting the sclera to relieve vitreoretinal traction. - It is not the initial or primary treatment for **proliferative diabetic retinopathy** or **neovascularization**.

Q: Which chemotherapy agents are commonly used for the treatment of retinoblastoma?

vincristine, carboplatin and etoposide. ***Vincristine, carboplatin and etoposide*** - This combination is a well-established and commonly used **chemotherapy regimen** for the systemic treatment of retinoblastoma, particularly when there is significant intraocular disease or extraocular extension. - **Vincristine** targets microtubules, **carboplatin** is an alkylating agent, and **etoposide** is a topoisomerase inhibitor, working together to achieve a synergistic antineoplastic effect. *Vinblastine, etoposide and bleomycin* - While etoposide is used, **vinblastine** is not a primary agent for retinoblastoma, and **bleomycin** is more commonly associated with germ cell tumors or lymphomas, not retinoblastoma. - This combination lacks the broad spectrum of activity and specific targeting for retinoblastoma that is present in the standard regimen. *Vinblastine, vincristine and etoposide* - Although vincristine and etoposide are used, **vinblastine** is not typically included in the first-line systemic chemotherapy for retinoblastoma. - The absence of a platinum agent like carboplatin would make this regimen less effective for retinoblastoma, which often requires a strong alkylating agent. *Vinblastine, vincristine and cisplatin* - While vincristine is appropriate, **vinblastine** is not a standard component, and **cisplatin** is an alkylating agent but **carboplatin** is generally preferred in retinoblastoma due to its similar efficacy and a more favorable toxicity profile, especially regarding nephrotoxicity. - The use of cisplatin can lead to more significant **renal toxicity** and potentially ototoxicity compared to carboplatin, which is often avoided in a pediatric population when alternatives exist.

Q: What conditions can the photostress test help differentiate between?

Macular and optic nerve diseases. ***Macular and optic nerve diseases*** - The **photostress test** assesses the functional recovery of the macula after exposure to bright light. - Patients with **macular dysfunction** will experience a prolonged recovery time of **visual acuity** (>60 seconds) compared to those with **optic nerve disease** or normal eyes, where recovery is typically faster. *Retinal and optic nerve diseases* - While the photostress test differentiates macular (a part of the retina) from optic nerve disease, "retinal diseases" is too broad, as it includes peripheral retinal conditions not directly assessed by macular function. - **Peripheral retinal diseases** may not significantly impact the photostress recovery time, making this option less precise. *Cataract and retinal diseases* - The photostress test is not primarily designed to differentiate between **cataracts** and **retinal diseases**. - **Cataracts** cause generalized reduced vision but do not typically prolong **photostress recovery** unless a significant **macular pathology** is co-existent. *Vitreous and optic nerve diseases* - **Vitreous opacities** or **hemorrhages** can cause scattered light and reduced vision, but they do not specifically prolong **macular recovery** after photostress in the same way **macular degeneration** does. - The test focuses on **photoreceptor recovery**, which is not directly affected by the vitreous.

Q: Silk retina is seen in ?

Retinal detachment. ***Retinal detachment*** - **"Silk retina" or "silky sheen"** is a classic ophthalmoscopic finding in retinal detachment, describing the **smooth, glistening appearance** of the detached sensory retina. - The detached retina appears **elevated, gray, and translucent** with characteristic folds or undulations, exhibiting a **satiny or silky luster** when examined. - Patients typically present with **photopsias (flashes of light)**, **floaters**, and progressive **visual field defect** described as a "curtain" or "shadow." - This is a true **ophthalmic emergency** requiring urgent surgical intervention. *Diabetic retinopathy* - Characterized by **microaneurysms, dot-blot hemorrhages, hard exudates**, and **cotton-wool spots** in non-proliferative stages. - Proliferative diabetic retinopathy shows **neovascularization** and vitreous hemorrhage. - Does not produce the "silk retina" appearance. *Macular degeneration* - Age-related macular degeneration presents with **drusen, pigmentary changes**, and in advanced stages, **geographic atrophy** or **choroidal neovascularization**. - May show a **"beaten-bronze" appearance** in certain macular dystrophies (Best's disease), but not "silk retina." - Central vision loss is the predominant symptom. *Hypertensive retinopathy* - Features include **generalized arteriolar narrowing, AV nicking, flame-shaped hemorrhages**, and **cotton-wool spots**. - In severe cases (Grade IV), **optic disc edema** and macular star exudates may occur. - Vascular changes dominate the clinical picture, not a silky retinal appearance.

Q: Muscae volitantes is seen in?

Vitreous detachment. ***Vitreous detachment*** - **Muscae volitantes** (Latin for "flying flies") is the classical term for **vitreous floaters** - **Posterior vitreous detachment (PVD)** is the **most common cause** of muscae volitantes - PVD occurs due to **vitreous liquefaction** and **vitreoretinal separation**, causing **collagen fibers and cellular debris** to cast shadows on the retina - These floaters are typically described as **spots, cobwebs, or threads** that move with eye movement - PVD is extremely common, particularly **after age 50-60 years**, and in **myopic patients** *Remains of primitive hyaloid vasculature* - **Hyaloid remnants** (such as **Mittendorf's dot** or **Bergmeister's papilla**) are **congenital developmental anomalies** - While these can occasionally be visible as small opacities, they are **not the classical cause** of muscae volitantes - These are typically **stationary** rather than "floating" as the term implies *Vitreous Hemorrhage* - Causes **sudden onset** of numerous floaters, often described as **"shower of red blood cells"** or dense black spots - Associated with **significant vision loss** and requires urgent evaluation - Not the benign, chronic floaters typical of muscae volitantes *Eale's disease* - **Peripheral retinal vasculitis** causing **recurrent vitreous hemorrhages** - Floaters occur secondary to **hemorrhage**, not the primary pathology of muscae volitantes - Presents with **recurrent episodes** and **vision loss**, not isolated benign floaters

Question 1

What is a common symptom associated with vitreous hemorrhage?

Accepted Answer

Sudden loss of vision without pain

Answer

Sudden loss of vision with pain

Answer

Gradual loss of vision with pain

Answer

Gradual loss of vision without pain

Question 2

Anterior uveitis earliest lesion ?

Accepted Answer

Aqueous flare

Answer

Keratic precipitates

Answer

Circumcorneal congestion

Answer

Blurring of vision

Question 3

Which gas is most commonly used with pneumatic retinopexy?

Accepted Answer

C3F8

Answer

CO2

Answer

N2

Answer

SF6

Question 4

In which type of retinal detachment are retinal tears most commonly observed?

Accepted Answer

Rhegmatogenous retinal detachment

Answer

Secondary retinal detachment

Answer

Tractional retinal detachment

Answer

Exudative retinal detachment

Question 5

A diabetic patient presents to you with visual acuity of 6/9 in one eye. Further investigations revealed preretinal hemorrhages with neovascularization at the optic disc. What is the next step in management?

Accepted Answer

Pan-retinal photocoagulation

Answer

Focal laser photocoagulation

Answer

Grid laser photocoagulation

Answer

Scleral buckling

Question 6

Which chemotherapy agents are commonly used for the treatment of retinoblastoma?

Accepted Answer

vincristine, carboplatin and etoposide

Answer

vinblastine, etoposide and bleomycin

Answer

vinblastine, vincristine and etoposide

Answer

vinblastine, vincristine and cisplatin

Question 7

What is the primary cause of exudative retinal detachment?

Accepted Answer

Inflammation and vascular abnormalities leading to fluid accumulation beneath the retina.

Answer

Traction on the retina causing detachment.

Answer

Retinal tear leading to fluid accumulation.

Answer

Fluid accumulation due to Coats' disease.

Question 8

What conditions can the photostress test help differentiate between?

Accepted Answer

Macular and optic nerve diseases

Answer

Retinal and optic nerve diseases

Answer

Cataract and retinal diseases

Answer

Vitreous and optic nerve diseases

Question 9

Silk retina is seen in ?

Accepted Answer

Retinal detachment

Answer

Diabetic retinopathy

Answer

Macular degeneration

Answer

Hypertensive retinopathy

Question 10

Muscae volitantes is seen in?

Accepted Answer

Vitreous detachment

Answer

Vitreous Hemorrhage

Answer

Remains of primitive hyaloid vasculature

Answer

Eale's disease

Diseases of the Retina — MCQs

Diseases of the Retina — MCQs

On this page

Practice by Chapter

Want unlimited practice?